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Tumour Necrosis Factor (TNF)-a, a pro-inflamma-
tory cytokine has a dual role in host immunity and 
immunopathology of tuberculosis and is considered to 
be pivotal for determining the clinical course of the 
disease, either beneficial or detrimental. The assess-
ment of TNF-a in pleural tuberculosis will help us to 
understand its role in host defence mechanism against 
Mycobacterium tuberculosis (MTB) infection. In this 
study, TNF-a and IFN-g levels were measured in plasma 
and pleural fluid of both tuberculosis (TB) and non-
TB patients and in the supernatants of blood and 
pleural fluid mononuclear cells (PBMCs and PFMCs) 
stimulated in vitro with PPD, culture filtrate and heat-
killed (MTB). In addition, apoptosis induced by PPD 
and MTB was also studied. TNF-a and IFN-g were 
significantly elevated in pleural fluid than in plasma 
of pleural tuberculosis patients, suggesting the com-
partmentalization of Th1 cytokine-secreting cells at 
the site of disease. In vitro stimulation of PFMCs with 
PPD and MTB showed a significant increase in these 
cytokine levels and also enhanced apoptosis of these 
cells. This increase in TNF-a levels may contribute to 
the containment of infection by synergizing with IFN-
g to activate infected macrophages or by the regula-
tion of T-cell apoptosis. 
TUBERCULOUS pleuritis occurs in about 30% of patients 
with tuberculosis (TB). This percentage increases with 
HIV-positive conditions. HIV-positive individuals tend  
to develop tuberculous pleuritis during the r early stage 
of immunosuppression1. The emergence of multi drug-
resistant tuberculosis (MDR-TB) has added burden to TB 
therapy. Currently, immunotherapeutic studies are being 
carried out to reduce the duration of therapy and to find 
an alternate treatment for MDR-TB. Tuberculous pleu-
ritis serves as the  best model to understand the immunity 
at the site of infection. The local cell-mediated immune 
(CMI) response generated by macrophages in coopera-
tion with T-lymphocytes in tuberculous pleuritis resolves 
the disease without chemotherapy. The response is medi-
ated by the secretion of complex cytokine pattern by the 
antigen-specific T-cells present in the pleural space. The 
cytokine pattern in tuberculous pleuritis is suggestive of 
TH1 type2,3. Cytokines like gamma interferon (IFN-g), 
Tumour Necrosis Factor (TNF)-a, IL-2, IL-12 and IL-18 
are the ones that play a major role in bringing about the 
reactions like granuloma formation, intramacrophage 
elimination of the bacill ry antigens and fibrosis that lead 
to the resolving of the disease4. 
 TNF-a is produced by macrophages, monocytes and 
dentritic cells in response to Mycobacteria or its prod-
ucts, or to other microorganisms like Listeria monocyto-
genes. It has immuno-regulatory properties and brings 
about the activation of macrophages, granuloma forma-
tion, T-cell stimulation and regulation of chemokine induc-
tion, thus controlling infection5. High levels of TNF-a 
were reported in chronic TB accompanied by the elevated 
release of TNF-a receptors resulting in fever, necrosis 
and weight loss. This implies that TNF-a has both pro-
tective and immunopathologic effects6. IFN-g, a TH1-
type cytokine is essential in TB immunity, which is the 
single most important factor for macrophage activation 
and TNF-a induction7. Individuals who lack either IFN-g 
or IFN-gR are highly susceptible to severe systemic infec-
tions which are important in the control of TB8,9. 
Apoptosis is a crucial phenomenon occurring at the 
site of infection in TB. Previous studies indicate that the 
microenvironment of a Mycobacterium tuberculosis (MTB)-
infected focus is favourable for apoptosis of mononuclear 
cells10,11. Infected macrophages secrete TNF-a, which 
acts as an important apoptotic factor. Assessment of TNF-
a, together with its inducer IFN-g, will help us formulate 
its functional role in apoptosis and to understand the  
local CMI response that results in the clearance of the 
bacilli. Moreover, most reports on TNF-a and IFN-g are 
from either in vivo levels or about in vitro studies, but not 
from both12–14. Hence we assessed these cytokine levels 
simultaneously, both in vivo and in vitro, with an idea to 
confirm previous reports from in vivo studies and extend 
them to in vitro results. 
 We included 75 patients from the Government General 
hospital, Chennai with pleural effusion. These patients 
were broadly divided into two groups according to the 
diagnosis. 
 
(i) A TB group consisting of 46 patients with tubercu-
lous pleural effusion. The effusion was unilateral. Diag-
nosis was confirmed by the clinical picture, AFB positi-
vity for the smear, culture positivity or positive by PCR. 
(ii) A non-TB (NTB) group of 29 patients with transu-
dative effusion due to causes other than tuberculous pleu-
ritis. This included patients with congestive cardiac 
failure and liver diseases. 
 
 The pleural fluid and blood collected for therapeutic 
and diagnostic purposes respectively, were utilized for 
this study according to the ethical guidelines of the  
Gov rnment General Hospital, Chennai. A written, infor-
med consent for participation in the study was obtained 
from each patient. Blood and pleural fluid were collected  
efore the start of the treatment. 
 Peripheral blood mononuclear cells (PBMCs) were 
isolated from the heparinized blood (10 U/ml) by Ficoll-‡For correspondence. (e-mail: sulochanadas@rediffmail.com) 
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Hypaque (Pharmacia) density gradient centrifugation, as 
described elsewhere15. To obtain pleural fluid mono-
nuclear cells (PFMCs), the heparinized pleural fluid 
(1 U/ml) was layered over Ficoll-Hypaque and centri-
fuged at 1800 rpm for 30 min The interphase was collec-
ted and washed twice with HBSS (Whittaker) at 1800 rpm 
for 10 min. PBMCs and PFMCs were suspended at the 
concentration of 1 × 0 6 cells/ml in RPMI 1640 (Sigma 
Chemical Co.) supplemented with 10% autologous serum. 
Viability of the cells was assessed by trypan blue exclu-
sion method. The cell-free plasma and pleural fluid were 
stored at – 70°C for assessment of cyt kines. 
 Only cells from those patients who were positive by all 
the diagnostic criteria (clinical, smear, culture and PCR) 
and for whom the cells were adequate were taken for 
in vitro studies. Accordingly, 18 out of 46 TB samples of 
tuberculous pleuritis were included in this study. Next, 
1 × 106 PBMCs and PFMCs were distributed in 48 well 
round-bottom plates (Nunclon) and incubated with differ-
ent mycobacterial antigens like PPD (Weybridge, UK), 
culture filtrate (CF) and heat-killed MTB at 10 mg/ml 
concentration. These cultures were incubated at 37°C in 
5% CO2. The CF antigen and heat-killed MTB were pre-
pared in our laboratory. Mononuclear cells incubated with 
medium alone served as control. Cell-free supernatants were 
collected after 48h at which the cytokine concentration 
were found to be maximum, and stored at – 70°C for  
cytokine estimation. TNF-a and IFN-g levels were meas-
ured in plasma and pleural fluid and in supernatants of in
vitro experiments using a commercial sandwich ELISA kit 
(R&D Systems, Minneapolis, USA) and following the manu-
facturer’s instruction. Diagnostic PCR using IS6110 primers 
(Bangalore Genei Private Limited, India) was performed 
to find the positivity for the presence of MTB bacilli. 
 For the detection of apoptosis 1 × 106 cells (PBMCs 
and PFMCs) of 10 out of the 18 TB patients chosen  
for in vitro studies, were treated with known apoptosis-
inducing agent like Dexamethasone (100 mg/ml) and myco-
bacterial antigens (PPD and MTB–50 mg/ml) for three 
days. The cells were harvested, permeabilized and stained 
with 500 ml of fluorochrome solution (200mg RNAase A 
(Amersham Corporation) and 100 mg propidium iodide 
(Sigma Chemical Co.) in Ca2+, Mg2+-free PBS and were 
incubated at 37°C for 1 h. Acquisition was done with 
FACSORT (Becton Dickinson, CA) and analysis was 
done using CellQuest software. The PI staining intensity 
of cells was determined by measuring the red fluore-
scence. The percentage of cells in the less than 2N region 
(hypoploidy) was taken as the quantitative measure of the 
apoptotic cells, as de cribed previously16. 
 Comparison between groups was done using paired or 
unpaired Student’s t test as appropriate for normally dis-
tributed data. Wilcoxon’s rank sum test was performed 
for the data that were not normally distributed. The val-
ues were expressed as mean ± st dard error of the mean, 
both in the text and in the figures. 
 With a view to understand the local in vivo role of 
TNF-a in relation with IFN-g, the mean TNF-a and IFN-
g concentrations in the plasma and pleural fluid of TB 
and NTB groups were assessed, the results are shown in 
Figure 1. The mean levels of TNF-a and IFN-g in pleural 
fluid were significantly higher (P < 0.05) than the plasma 
levels in patients with tuberculous pleuritis. There was no 
significant difference between the plasma and pleural 
fluid levels in transudative effusions from the NTB  
patients. A number of studies have been reported on  
the protective role of IFN-g and TNF-a in TB8,9,17, and 
higher levels of these cytokines in pleural fluid than in 
plasma of tuberculous pleuritis pat ents14,18. The selective 
increase observed in these cytokine levels in pleural fluid 
supports these studies. The high concentration of these 
cytokines in pleural fluid reflects the stimulation of local, 
immuno-reactive cells by mycobacteri l components that 
faci itate bacillary elimination and granuloma formation. 
Moreover, it also suggests that there is a compartmentali-
zation of TH1 cytokine-secreting cells, as reported earlier19. 
This compartmentalization occurs because of the migra-
tion of TNF-a and IFN-g secreting cells to the site of the 
disease and hence not accessible through the sampling of 
plasma of peripheral blood, thus attributing to the lesser 
plasma levels of these cytokines in tuberculous pleuritis 
patients than in NTB patients. The comparable in vivo 
levels of TNF-a in pleural fluid of NTB patients with 
that of TB patients may be due to the generalized TNF-a 
secretory response to any inflammatory conditions, but 
not due to compartmentalization. This is evdent from the 
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Figure 1. In vivo levels of TNF-a (a) and IFN-g (b) in plasma (BL) 
and pleural fluid (PF) of patients with tuberculous pleurisy (TB) and 
patients with effusions other than tuberculosis (Non-TB); *P < 0.05. 
a 
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similar levels of TNF-a noticed in the plasma and pleural 
fluid of NTB patients. 
 Observing the enhanced response of TNF-a in vivo, we 
further decided to investigate its in vitroresponse to the 
widely used crude mycobacterial antigens. The levels of 
TNF-a and IFN-g in the supernatants of PBMCs stimu-
lated with PPD, CF and MTB did not show any difference 
when compared with their control levels. This implies 
that the TNF-a and IFN-g secreting cells present in the 
PBMCs population are not specific for MTB antigens. 
However, PFMCs stimulated with PPD and MTB but not 
with CF, showed significant increase when compared 
with their control levels (P <0.05; Figure 2). This sug-
gests that these cells are specific for my obacterial com-
ponents. The increase in the cytokine response may be 
due to the memory response of the cells towards the myco-
bacterial antigens. Overall, the in vitro levels of TNF-a in 
the supernatants of PBMCs were higher than those found in 
the supernatants of PFMCs under all stimulated conditions. 
 Apoptosis is a feature of tuberculous granulomata in 
pulmonary TB. Previous in vitro study from TB patients 
has reported that there occurs T- ell hyporesponsiveness 
linked to spontaneous or MTB-induced apoptosis of T-
cells20. Thus PFMCs at the site of infection constitute the 
mycobacterial antigen-sensitized population and hence 
are more prone to apoptosis. Our results showed the induc-
tion of apoptosis of PFMCs by mycobacterial antigens 
(Figure 3). As expected, we observed maximum sponta-
neous apoptosis (21%) occurring in PFMCs compared to 
PBMCs (5%) when there is no stimulation. Also, a known 
apoptotic agent like Dexamethasone induced maximum 
apoptosis (43%) in PFMCs. With mycobacterial antigens, 
marginal apoptosis (12–18%) was seen in PBMCs while 
PFMCs showed significantly high (34–45%) levels of 
apoptosis. We have also observed that it is the T-cell 
population of PFMCs that undergoes enhanced apoptosis 
(S. Das unpublished data). Such spontaneous or MTB-
induced apoptosis of T-cells has been previously docu-
mented21,22. In another study based on pleural tuberculosis, 
the loss of IFN-g-producing cells was found to be limited 
specifically to MTB-responsive cells23. These studies pro-
vide evidence that T-cell apoptosis is biologically sig-
nificant in the disease process. 
 Most studies indicate a critical role for TNF-a and 
IFN-g in the apoptosis mediated by MTB11,20,24. Associa-
tion between the high levels of these cytokines and  
enhanced apoptosis of PFMCs in our study indicates that 
these cytokines have a dual role at the site of infection. 
As known, IFN-g induces TNF-a, which plays an immuno-
prot ctive role by containing MTB infection and facilitating 
granuloma formation. On the other hand, it can also bring 
about the apoptosis of sensitized T-cells, that has immuno-
pathologic outcomes. The immunopathol gic role of IFN-g 
is also supported by the recent obs rvation of its role in 
upregulating the transcription of genes involved in apop-
tosis (FasL, Fas, Bak)25–27. 
 It is reported that the TNF-a-mediated pathology occurs 
only in the presence of IL-4 in certain inflammatory con-
ditions, including TB, at the systemic level28. We extend 
this finding to the localized response in TB. Supporting 
this, we found an increase in in v tro levels of IL-4 (data 
communicated) in these patients, suggesting the tilt of 
immune response towards TH2/Th0 type. This increase 
in IL-4 production in response to MTB possibly influ-
e ces the sensitization of T-lymphocytes to apoptosis by 
 TNF-a-mediated pathway, as suggested by Seah and 
Rook29. Cytokine profile-dependent action of TNF-a also 
suggests that the tissue damage was caused by TNF-a in 
the mixed TH1 + TH2/Th0 response30. 
 In conclusion, the threshold levels of TNF-a may con-
tribute to the containment of the infection by synergizing 
 
 
Figure 3. Apoptosis of PBMCs and PFMCs in 10 TB patients det cted
by flow cytometry. Cells were treated with known apopt sis-inducing 
agent – Dexamethasone (DEX) and with mycobacterial antigens PPD 
and heat-killed MTB. 
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Figure 2. In vitro production of TNF-a (a) and IFN-g (b) by PBMCs 
and PFMCs of TB patients stimulated with PPD, culture filtrate (CF) 
and heat-killed Mycobacterium tuberculosis (MTB); *P < 0.05. 
 
a  
b 
RESEARCH COMMUNICATIONS 
CURRENT SCIENCE, VOL. 85, NO. 5, 10 SEPTEMBER 2003 642
with IFN-g to activate infected macrophages, or by  
the regulation of T-cell apoptosis; whereas the selective 
depletion of mycobacterium-reactive cells that secrete 
TNF-a may lead to enhanced susceptibility to MTB  
infection and result in the dissemination of the bacilli. 
Thus, TNF-a plays an immunoregulatory role in TB. In 
addition, we speculate that the high levels of IL-4  
observed in our studies may also contribute to apoptosis 
in a TNF-a-dependent manner. It is interesting to note 
from our studies that the two antagonistic cytokines, viz. 
IFN-g and IL-4 bring about the same effect of apoptosis 
mediated through TNF-a. However, further experiments 
should focus on finding the conditions and mechanisms 
by which these cytokines bring about apoptosis to eluci-
date the functional role of TNF-a in apoptosis. Under-
standing such basic mechanisms would help us explore 
new therapeutic strategies for TB. 
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